ArticleOncoimmunology2016

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA.

Nadia Mensali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.